Renalytix plc (RNLXY) Free cash flow 2019–2024
Renalytix plc (RNLXY) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$30.1MFY2024 · since FY2019: -$6.5M → -$30.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$30.1M | +11.6% |
| FY2023 | -$34.1M | +26.7% |
| FY2022 | -$46.5M | -59.3% |
| FY2021 | -$29.2M | -182.5% |
| FY2020 | -$10.3M | -59.7% |
| FY2019 | -$6.5M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More RNLXY financial trends
RNLXY RevenueRNLXY Net incomeRNLXY Net marginRNLXY Gross profitRNLXY Gross marginRNLXY Operating incomeRNLXY Operating marginRNLXY Operating cash flowRNLXY Capital expendituresRNLXY Return on equityRNLXY Stock buybacksRNLXY Dividends paidRNLXY Total assetsRNLXY Total liabilitiesRNLXY Shareholders’ equityRNLXY overview →